Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately to Severely Active Ulcerative Colitis (UC)”

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05494606
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice

Who this might be right for
Ulcerative Colitis
AbbVie 785
Early research (Phase 1)Study completedNCT04254783
What this trial is testing

Evaluate the Effect of Intravenous (IV) Infusions of Risankizumab on Pharmacokinetics of Cytochome P450 Substrates in Adult Participants With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative Colitis (UC)Crohn's Disease
AbbVie 20
Large-scale testing (Phase 3)Study completedNCT04706793
What this trial is testing

Oral Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis in Adult Japanese Participants (ELEVATE UC 40 JAPAN)

Who this might be right for
Ulcerative Colitis
Pfizer 42
Testing effectiveness (Phase 2)Active Not RecruitingNCT05731128
What this trial is testing

Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))

Who this might be right for
Colitis Ulcerative
Sanofi 68
Testing effectiveness (Phase 2)Looking for participantsNCT07507513
What this trial is testing

The Purpose of This Study is to Evaluate the Efficacy and Safety of 627 in the Treatment of UC

Who this might be right for
Ulcerative Colitis (UC)
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 288
Not applicableStudy completedNCT05791526
What this trial is testing

An Observational Study to Assess Change in Disease Activity and Adverse Events of Rinvoq in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Japan

Who this might be right for
Ulcerative Colitis
AbbVie 308
Large-scale testing (Phase 3)Study completedNCT02165215
What this trial is testing

The Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Colitis, Ulcerative
Hoffmann-La Roche 359
Large-scale testing (Phase 3)Ended earlyNCT05644665
What this trial is testing

Evaluate Efficacy and Long-term Safety of Oral Ozanimod in Chinese Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 131
Testing effectiveness (Phase 2)Study completedNCT01294410
What this trial is testing

Induction and Maintenance Study of BMS-936557 Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Bristol-Myers Squibb 305
Large-scale testing (Phase 3)Study completedNCT02819635
What this trial is testing

Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 1,302
Testing effectiveness (Phase 2)Study completedNCT04504383
What this trial is testing

PN-943 in Adults With Moderate to Severe Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis Chronic ModerateUlcerative Colitis Chronic Severe
Protagonist Therapeutics, Inc. 169
Testing effectiveness (Phase 2)Active Not RecruitingNCT06290934
What this trial is testing

Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Gilead Sciences 228
Post-approval studies (Phase 4)Study completedNCT02318667
What this trial is testing

Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).

Who this might be right for
Colitis, Ulcerative
Merck Sharp & Dohme LLC 38
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07535489
What this trial is testing

Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2)

Who this might be right for
Moderately to Severely Active Ulcerative Colitis (UC)
Nanjing Immunophage Biotech Co., Ltd 144
Large-scale testing (Phase 3)Active Not RecruitingNCT05782907
What this trial is testing

Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
AbbVie 122
Testing effectiveness (Phase 2)Ended earlyNCT03298022
What this trial is testing

Efficacy&Safety of ALTB-168 in Patients With Moderate to Severe Active,Anti-TNF Alpha and/or Anti-integrin Refractory UC

Who this might be right for
Ulcerative Colitis
AltruBio Inc. 24
Testing effectiveness (Phase 2)Ended earlyNCT01659138
What this trial is testing

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Sanofi 28
Testing effectiveness (Phase 2)Ended earlyNCT04677179
What this trial is testing

LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Colitis, Ulcerative
Nektar Therapeutics 81
Testing effectiveness (Phase 2)Study completedNCT05377580
What this trial is testing

Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
Innovent Biologics (Suzhou) Co. Ltd. 150
Not applicableLooking for participantsNCT06073873
What this trial is testing

A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea

Who this might be right for
Ulcerative Colitis
Bristol-Myers Squibb 3,000
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation